Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome

Not Applicable

Completed

• Conditions: Hyperventilation Syndrome

• Registration Number: NCT04668638
• Lead Sponsor: Centre Hospitalier Régional d'Orléans

Brief Summary

The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it is a benign affection, its associated comorbidities and symptomatology greatly decrease the patients' quality of life. Yet, no medicinal treatments have been proved useful, but prescribers noticed improvements after physiotherapy. Given that the physiotherapy impact on hyperventilation syndrome is not well described in the literature, this study aims to scientifically ascertain physiotherapy benefits on quality of life and symptomatology in hyperventilation syndrome-suffering patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-12-09
• Study First Submitted QC: 2020-12-09
• Study First Posted: 2020-12-16
• Study Start: 2021-03-10
• Status Verified: 2025-07
• Primary Completion: 2025-07-01
• Study Completion: 2025-07-01
• Last Update Submitted: 2025-07-17
• Last Update Posted: 2025-07-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

• Positive hyperventilation syndrome diagnosis
• Having a social security insurance
• Being at least 18 years old
• Having given their written consent

Exclusion Criteria

• Being put under guardianship or curatorship
• Having seen a physiotherapist for a respiratory rehabilitation in the last three months
• Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, ...)
• Not being able to receive the respiratory rehabilitation from our care providers
• Already having received a rehabilitation for hyperventilation syndrome
• Not speaking French or not being unable to complete the questionnaires

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Incidence of respiratory rehabilitation on Quality of life	Month 4	Quality of life will be evaluated with the SF-36 score

Secondary Outcome Measures

Name	Time	Method
Change in symptomatology	Month 4	Change in symptomatology will be evaluated on the Nijmegen questionnaire

Trial Locations

Locations (1)

CHR d'Orléans; 🇫🇷 Orléans, France